Ensign Peak Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $168K | Hold |
|
|||||
|
2025
Q1 | $280K | Hold |
|
|||||
|
2024
Q4 | $433K | Hold |
|
|||||
|
2024
Q3 | $866K | Hold |
|
|||||
|
2024
Q2 | $773K | Hold |
|
|||||
|
2024
Q1 | $674K | Sell |
|
|||||
|
2023
Q4 | $635K | Buy |
|
|||||
|
2023
Q3 | $262K | Hold |
|
|||||
|
2023
Q2 | $379K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $538K | Hold |
|
|||||
|
2022
Q2 | $512K | Hold |
|
|||||
|
2022
Q1 | $710K | Hold |
|
|||||
|
2021
Q4 | $778K | Sell |
|
|||||
|
2021
Q3 | $2.03M | Hold |
|
|||||
|
2021
Q2 | $1.92M | Hold |
|
|||||
|
2021
Q1 | $1.91M | Hold |
|
|||||
|
2020
Q4 | $1.24M | Hold |
|
|||||
|
2020
Q3 | $819K | Hold |
|
|||||
|
2020
Q2 | $712K | Hold |
|
|||||
|
2020
Q1 | $899K | Buy |
|
|||||
|
2019
Q4 | $1.55M | Buy |
|